Robot-assisted resection of benign splenic tumors in children

Purpose Robotic surgery is becoming increasingly widely used in the field of pediatric surgery. The present study aimed to evaluate the safety and feasibility of robot-assisted resection of benign pediatric splenic tumors and to discuss the technical points. Methods A total of 32 patients who were diagnosed with benign splenic tumors and underwent minimally invasive surgery from January 2017 to September 2023 were included in the study. The clinical data including demographic criteria, operative details, and postoperative outcomes were analyzed retrospectively. Results Thirteen patients underwent robot-assisted surgery, and 19 patients underwent laparoscopic surgery. The median operation time was 150 min, with an interquartile range (IQR) of 120 to 200 min for the robot-assisted group and 140 min with an IQR of 105 to 180 min in the laparoscopic group ( P = 0.318). Despite four cases in the laparoscopic group (21%) being converted to laparotomy because of intraoperative bleeding, compared with none in the robot-assisted group, there was no significant difference between two groups ( P = 0.128). The intraoperative volume of blood loss was significantly less ( P = 0.041), and the hospitalization expense was significantly higher ( P = 0.000) in the robot-assisted group than for the laparoscopic group. There was no significant difference in patients’ age, tumor size, postoperative feeding time, and the postoperative hospitalization time between two groups ( P > 0.05). Conclusion Robot-assisted benign splenic tumor resection was safe and feasible, and it reduced surgical trauma for the pediatric patient.